Processing of C5a by human polymorphonuclear leukocytes

Journal of Leukocyte Biology

Volumn 63, Issue 4, 1998, Pages 456-462

  Hetland, Geir ^a   Pfeifer, Philippe H ^a   Hugli, Tony E ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Complement activation product; Metabolism; Neutrophils

Indexed keywords

COMPLEMENT COMPONENT C5A;

ARTICLE; COMPLEMENT ACTIVATION; HUMAN; HUMAN CELL; INTERNALIZATION; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN PROCESSING; RADIOIMMUNOASSAY;

EID: 0031956956     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.63.4.456     Document Type: Article

References (37)

1. Jose, P. J., Forrest, M. J., Williams, T. J. (1981) Human C5a des Arg increases vascular permeability. J. Immunol. 127, 2376-2380.
2. Marceau, F., Hugli, T. E. (1984) Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels. J. Pharmacol. Exp. Ther. 230, 749-754.
3. Regal. J, F., Pickering, R. J. (1997) C5a and antigen-induced tracheal contraction: effect of a combination of an anthihistamine and cyclooxygenase inhibitors. Int. J. Immunopharmacol. 5, 71.
4. Stimler, N. P., Brocklehurst, W. E., Bloor, C. M., Hugli, T. E. (1981) Anaphylatoxin-mediated contraction of guinea pig lung strips: a nonhistamine tissue response. J. Immunol. 126, 2258-2261.
5. Grossklaus, C., Damerau, B., Lemgo, E., Vogt, W. (1976) Induction of platelet aggregation by the complement-derived peptides C3a and C5a. Naunyn-Schmiedebergs Arch. Pharmacol. 295, 71.
6. Meuer, S., Ecker, U., Hadding, U., Bitter-Suermann, D. (1981) Platelet-serotonin release by C3a and C5a: two independent pathways of activation. J. Immunol. 126, 1506.
7. Chenoweth, D. E., Rowe, J. G., Hugli, T. E. (1979) A modified method for chemotaxis under agarose. J. Immunol. Meth. 25, 337-353.
8. Webster, R. O., Zanolari, B., Henson, P. M. (1981) Neutrophil chemotaxis in response to surface-bound C5a. Exp. Cell Res. 129, 55.
9. McPhail, L. C., Snyderman, R. (1983) Activation of the respiratory burst enzyme in human polymorphonuclear leukocytes by chemoattractants and other soluble stimuli. Evidence that the same oxidase is activated by different transductional mechanisms. J. Clin. Invest. 72, 192.
10. Becker, E. L., Showell, H. J., Henson, P. M., Hsu, L. S. (1974) The ability of chemotactic factors to induce lysosomal enzyme release. I. The characteristics of the release, the importance of surfaces and the relation of enzyme release to chemotactic responsiveness. J. Immunol. 112, 2047.
11. Damerau, B. E., Grunefeld, E., Vogt, W. (1980) Aggregation of leukocytes induced by the complement-derived peptides C3a and C5a and by three, synthetic formyl-methionyl peptides. Int. Arch. Allergy Appl. Immunol. 63, 159-169.
12. Chenoweth, D. E., Goodman, M. G. (1983) The C5a receptor of neutrophils and macrophages. Agents Actions 12, 252-273.
13. Chenoweth, D. E., Hugli, T. E. (1978) Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. USA 75, 3943-3947.
14. Gerard, N. P., Gerard, C. (1991) The chemotactic receptor for human C5a anaphylatoxin. Nature 349, 614-617.
15. Williams, L. T., Snyderman, R., Pike, M. C., Lefkowitz, R. J. (1977) Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. USA 74, 1204-1208.
16. Haviland, D. L., McCoy, R. L., Whitehead, W. T., et al. (1995) Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung. J. Immunol. 154, 1861-1869.
17. Hugh, T. E. (1986) Biochemistry and biology of anaphylatoxins. Complement 3, 111-127.
18. Oppermann, M., Goetze, O. (1994) Plasma clearance of the human C5a anaphylatoxin by binding to leucocyte C5a receptors. Immunol. 82, 516-521.
19. Chenoweth, D. E., Hugli, T. E. (1980) Human C5a and C5a analogs as probes of the neutrophil C5a receptor. Mol. Immunol. 17, 151-161.
20. Huey, R., Hugli, T. E. (1985) characterization of a C5a receptor on human polymorphonuclear leukocytes (PMN). J. Immunol. 135, 2063-2068.
21. Van Epps, D. E., Simpson, S., Bender, J. G., Chenoweth, D. E. (1990) Regulation of C5a and formyl peptide receptor expression on human polymorphonuclear leukocytes. J. Immunol. 144, 1062-1068.
22. Van Epps, D. E., Simpson, S., Johnson, R. (1993) Relationship of C5a receptor modulation to the functional responsiveness of human polymorphonuclear leukocytes to C5a. J. Immunol. 150, 246-252.
23. Chenoweth, D. E., Hugli, T. E. (1980) Binding and degradation of C5a by human neutrophils. J. Immunol. 124, 1517.
24. Böyum, A. (1968) Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation and of granulocytes by combined centrifugation and sedimentation at one g. Scand. J. Clin. Lab. Infest. 21, 77.
25. Ferrante, A., Thong, Y. H. (1978) A rapid one-step procedure for purification of mononuclear and polymorphonuclear leukocytes from human blood using a modification of the Hypaque-Ficoll technique. J. Immunol Meth. 24, 389.
26. Hugli, T. E., Gerard, C., Kawahara, M., et al. (1981) Isolation of three separate anaphylatoxins from complement-activated human serum. Mol. Cell. Biochem. 41, 59-66.
27. Hubbard, A. L., Cohn, Z. A. (1972) The enzymatic iodination of the red cell membrane. J. Cell Biol. 55, 390.
28. Marchaloniz, J. J. (1969) An enzymatic method for the trace iodination of immunoglobulins and other proteins. Biochem. J. 113, 299.
29. Laemmli, U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
30. Smith, C. W., Hollers, J. C., Patrick, R. A., Hassett, C. (1979) Motility and adhesiveness in human neutrophils. J. Clin. Invest. 63, 221-229.
31. Chenoweth, D. E., Cooper, S. W., Hugli, T. E., Stewart, R. W., Blackstone, E. H., Kirklin, J. W. (1981) Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N. Engl. J. Med. 304, 497-503.
32. Morgan, E. L., Ember, J. A., Sanderson, S. D., et al. (1993) Anti-C5a receptor antibodies. Characterization of neutralizing antibodies specific for a peptide, C5aR-(9-29), derived from the predicted amino-terminal sequence of the human C5a receptor. J. Immunol. 151, 377-388.
33. Strieter, R. M., Kasahara, K., Allen, R. M., et al. (1992) Cytokine-induced neutrophil-derived interleukin-8. Am. J. Pathol. 141, 397-407.
34. Kajita, T., Hugli, T. E. (1991) Evidence for in vivo degradation of C3a anaphylatoxin by mast cell chymase. I. Nonspecific activation of rat peritoneal mast cells by C3ades Arg. Am. J. Pathol. 138, 1359-1369.
35. Bergh, K., Iversen, O. J. (1992) Production of monoclonal antibodies against the human anaphylatoxin C5a des Arg and their application in the neoepitope-specific sandwich-ELISA for the quantification of C5a Arg in plasma. J. Immunol. Meth. 152, 79-87.
36. Chenoweth, D. E., Hugli, T. E. (1982) Assays for chemotactic factors and anaphylatoxins. In Immunological Analysis. Recent Progress in Diagnostic Laboratory Immunology. (R. B. Nakamura, W. R. Ditto, and E. S. Tucker, III, eds.), Masson, New York, 227-237.
37. Heiland, G., Moen, O., Bergh, K., et al. (1997) Both plasma- and leukocyte-associated C5a are essential for assessment of C5a generation in vivo. Ann. Thorac. Surg. 63, 1076-1080.